Cellular imaging and surface marker labeling of hematopoietic cells using quantum dot bioconjugates

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Hematology

Background:

• Semiconductor quantum dots (qdots) possess unique optical properties, making them attractive fluorescent labels for laboratory diagnostics.
• Despite their potential, qdot-based probes require further development and evaluation for clinical laboratory applications.

Purpose of the Study:

• To evaluate two distinct methods for labeling hematopoietic cells using semiconductor quantum dots (qdots).
• To assess the feasibility of qdots for cell labeling and surface marker analysis in hematopoietic cells for clinical laboratory use.

Main Methods:

• Intracellular delivery of qdots via qdot-transferrin conjugates using receptor-mediated endocytosis.
• Cell surface marker labeling using qdot-conjugated monoclonal antibodies targeting CD5, CD19, and CD45 antigens.
• Detection and analysis of qdot signals using fluorescence microscopy and flow cytometry.

Main Results:

• Successful labeling of hematopoietic cells from umbilical cord blood and bone marrow with qdot-transferrin, with signals localized intracellularly.
• Specific binding of qdot-antibody conjugates to target cell surface markers on lymphocytes.
• Detection of bright, target-specific, and photostable qdot signals.

Conclusions:

• Semiconductor quantum dots are feasible for labeling hematopoietic cells and analyzing cell surface markers.
• Qdots offer superior optical properties compared to conventional fluorescent dyes.
• Qdot-based probes present a promising tool for hematology analysis in clinical laboratories.